Jane Street
ACXP icon

Jane Street’s Acurx Pharmaceuticals ACXP Stock Holding History

Jane Street’s Portfolio ACXP Stock Details ACXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$203K Buy
54,642
+43,899
+409% +$125K ﹤0.01% 10122
2025
Q4 		$26.8K Buy
+10,743
New +$51.5K ﹤0.01% 10668
2025
Q3 		– Sell
-1,401
Closed -$14.3K – 10666
2025
Q2 		$14.3K Buy
+1,401
New +$11.3K ﹤0.01% 9387

Other funds holding ACXP

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
PFS
Prospect Financial Services Melville, New York $164M AUM 19.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.33B AUM 24% 1-Year Est. Return

Jane Street's ACXP Position: Q1 2026 in Review

Jane Street increased its Acurx Pharmaceuticals (ACXP) stake by 409% in Q1 2026, buying an estimated $125K and bringing the position to 54,642 shares worth $203K. The position accounts for ﹤0.01% of the portfolio, ranked #10122.

Jane Street first reported a position in ACXP in Q2 2025 and has held it in 3 quarters since. 21 funds tracked by Wall St. Rank hold ACXP as of Q1 2026.

  • Jane Street held 54,642 shares of Acurx Pharmaceuticals worth $203K as of Q1 2026.
  • Jane Street bought 43,899 Acurx Pharmaceuticals shares in Q1 2026, an estimated $125K.
  • Acurx Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #10122 holding.
  • Jane Street first reported a position in Acurx Pharmaceuticals in Q2 2025 and has held it in 3 quarters since.
  • 21 funds tracked by Wall St. Rank held Acurx Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.